“Pharmacokinetic Model for Atomoxetine in Children with ADHD Suggests Potential for Activity Score-Based Dosing Recommendations”

https://pubmed.ncbi.nlm.nih.gov/38117180

This study developed a pharmacokinetic model for atomoxetine and its metabolites in children with ADHD, showing that CYP2D6 activity score significantly affects atomoxetine clearance and metabolite exposure, suggesting the potential for activity score-based dosing recommendations.